Maternal-fetal medicine specialist first in US to lead clinical trial on life-threatening fetal blood disorder
University of Texas Health Science Center at HoustonAn investigational drug that may block harmful antibodies from passing through the placenta of an expectant mother to the fetus is the focus of a new clinical trial led by Kenneth Moise, MD, a maternal-fetal medicine specialist at UTHealth.